Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Supportive care in hematologic malignancies

S Fetscher1, R Mertelsmann

  • 1Department of Internal Medicine, Freiburg University Medical Center, Freiburg im Breisgau, Germany.

Current Opinion in Hematology
|September 25, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automatic feedback control by image processing for mixing solutions in a microfluidic device.

Biomicrofluidics·2022
Same author

Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Treatment of Philadelphia Chromosome Positive (Ph +) Chronic Myelogenous Leukemia in Blast Crisis and Ph + Acute Leukemia with High Dose Cytosine Arabinoside (HDARAC).

Leukemia & lymphoma·2016
Same author

[Current treatment concepts of lung cancer].

Deutsche medizinische Wochenschrift (1946)·2011
Same author

Long-term remission after CD34+-selected PBSCT in a patient with advanced intra-abdominal desmoplastic small round-cell tumor.

Bone marrow transplantation·2009
Same author

Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's view.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques·2007
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

This review covers recent advances in supportive care for hematologic malignancies, focusing on hematopoietic growth factors, cytoprotective agents, and transfusion therapies to improve patient outcomes.

Area of Science:

  • Hematology
  • Oncology
  • Supportive Care

Background:

  • Supportive care is crucial for managing hematologic malignancies.
  • Recent advancements offer new strategies for patient management.

Purpose of the Study:

  • To review recent developments in supportive care for hematologic malignancies.
  • To highlight new insights into hematopoietic growth factors, cytoprotective agents, and transfusion therapies.

Main Methods:

  • Literature review of recently published developments.
  • Focus on established and emerging hematopoietic growth factors (HGFs).
  • Analysis of amifostine, decitabine in myelodysplastic syndromes (MDS), infectious complications, and transfusion therapy.

Main Results:

Related Experiment Videos

  • New data on benefits and risks of G-CSF and GM-CSF.
  • Emerging roles for KGF and thrombopoietin.
  • Updated information on amifostine, decitabine in MDS, infections, and granulocyte transfusions.

Conclusions:

  • Recent advancements in supportive care offer improved management options.
  • Continued research is vital for optimizing supportive care in hematologic malignancies.
  • Key areas include growth factors, cytoprotection, and transfusion strategies.